Searched for
STERILE ONCOLOGY FORMULATIONS
Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore- Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...03 Sep, 2026, 09.16 PM IST
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...09 Aug, 2026, 11.40 AM IST
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...28 Jul, 2026, 11.49 PM IST
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...26 Jun, 2026, 11.31 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...23 Apr, 2026, 06.00 AM IST
- Zydus Lifesciences inks licensing, commercialisation pact with RK PharmaZydus Lifesciences has partnered with RK Pharma Inc of the US. They will collaborate on a new sterile injectable oncology supportive care p...26 Nov, 2025, 02.48 PM IST
- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...28 Jun, 2025, 04.28 PM IST
- Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...24 Feb, 2025, 06.10 PM IST
- Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI...28 Oct, 2024, 03.34 PM IST
- This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...05 Sep, 2024, 04.11 PM IST
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...15 Aug, 2024, 03.07 PM IST
- Gland Pharma IPO: Issue date, price band & other key detailsThe drugmarker will likely announce the name of anchor investors by the end of Friday.06 Nov, 2020, 02.17 PM IST
- Sun Pharma gets USFDA nod for cancer treatment injectionThe approval from the USFDA is for INFUGEM injection (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use ...18 Jul, 2018, 01.32 PM IST
- Strides Acrolab: Drug licence, supply gains turn it onTHE Bangalore-based pharma major, Strides Arcolab, saw its stock price rising by 8% on Wednesday on the back of news of the company collabo...08 Jan, 2010, 10.08 AM IST
- Strides, Aspen ink four JVs to strengthen niche armsIt is raining deals at Bangalore-based mid-sized pharma player Strides Arcolab.21 Nov, 2007, 01.37 AM IST
Load More
